for year amazing progress now opportunity a beyond. at tobacco and unit seen an transformative well to been and It's John. positive the cashflow Thanks, as business
rich pharmaceutical faster turn kilos XXXX in intend of broad same packaged have leader for hemp in even servicing products And selling quarter active goods, an ingredients consumer discuss of into we cannabinoid XXXX. a volumes and the derived Slide timeline. the growing. accelerated XX America and hemp/cannabis for the and global do in as with footprint on fourth of is industries, the extracts GVB Let's and manufacturing to nutraceutical XXX,XXX finished market to hemp North we how
Grass a achieve planned exceeded deliveries fourth revenue positive to in more operations our due cash detail. the November had margin original positive of setback customer plans all the regardless I'll aggressively maintain and Valley we targets combination in even to scale which fire, enhancement, cash responded We primarily into with go for XXXX and though our quarter. a impacted We and operating
management. our why even is built. truly we have GVB it. plant sets goods category we science This This have been was from what vertically here's integrated have complete it that to we now for. building is retail to building and been ingredients finish apart And receptor What what control
our starts fully Slide of XX output month by underpinning extraction Oregon expected an world-class end facility XXXX. the per capacity Prineville, manufacturing with covers kilos chain. This of assets XX,XXX integrated the ingredient a in with
has third-party distillate from of temporarily injected will They're production market. the a it in purchases our year-end the scales, facility which this capacity Valley As November, our replacing Grass results. into displace isolate crude lot of cost a majority fire one-time our and
are for a superior We to It a sheet to balance in will recover campus and build fortunate cannabis/hemp excellence the have economic both an strong far center long-term be absolute insurance scalability. fully even of efficiency back world. coverage and
variety for Vegas extensive XX,XXX our products our will manufacturing there, agreement, can This and of distribution square is our From with this repeat of product synergies. an sales CDMO+D white produce customers. capability label a site tremendous leverage team new VLN foot Las VLN the I'll an consumer market I'll for which a the Again, teams distraction accelerant of not cover amount shortly.
industry. trial European in seven clinical at top finally, Europe an These margin, conducting these to even strong revenue, to filed pharmaceutical we market immediate but allow for and to market footprint to U.K. nutraceuticals create start And DMF long-term in have volumes U.K. have trials quickly allow that landed in new CBD go used very RXP food ingredients a be we as opened FDA would the the speak. acquired supplying to to our a years facilities clinical the with the revenues companies five the emerging to that the clinical isolate are due access and sales the also by not they out in We've higher take trials and multibillion-dollar
complete Slide on more XX Grass provides update Valley.
our situation doing remind that will and thankfully, I the foremost, from and are employees all were First safely of extracted you well.
the able fourth still standards customers our we're Next, source and ingredients, and supply products in certify we to to quarter. them our delivered
is actually volume goal. already fact, almost in sequentially shipped to In with revenue January. growth kilos XX,XXX XXXX increased into we our and XX% by volumes That XX,XXX hit continuing kilos,
this a the We provides and seeing the hemp premium our consistently. source marketplace ability in of as to grows. shortage supply And are raw to market a
a to We comprehensive gets distillate our campus then us are standing efficiency Valley margin interim Prineville cashflow original up have which an progresses, XXXX could will support production, and Grass in recovery enabled. greater as for and facility scalability that positive, builds economic enable isolate than and will
well with key office We're state Oregon in governor's the also working as for their economic directly agency incentives. development as
retail are to our brand channel We model partnership shelf. expertise. is CPG say cannabis model, an this, capabilities leverages the XX top Slide the the new This details key established from brands scale in distribution turnkey opportunity but several we verticalizing There and for way this management business brands to CDMO+ world-class a the cannabis/hemp the exclusive ingredients cornerstone looking pioneering is should distributed consumer revenue, very the space. source with announce ultimately GVB, to and retail by soon. manufacture to solution license expansion no for and other a our profit in units and offers transformative solutions
seeking team and CBD products. and high high velocity, placed retailers margin to enables small sales with also channel It further products footprint VLN our consumer innovative leverage us
or one move are will opportunities. on be scale several and deals these to transformative two excited the revenue Just to of forward we
XX, Moving European Slide position improved. in to greatly the has our also higher market margin
Our faster and tariffs import other to European duties and supports inclusive market. our landed Netherlands $X cost than facility customers, billion of growing delivery and more warehouse
a than marketplace more GVB global of pathway ingredients. accounts. and are with novel ingredients core and provide and for brings applications, securities acquisition applications the exciting massive food for beverage and large intended footprint GVB's form consumer that and an high-quality market beverage a data of play products RXP nutraceutical food XXXX Our U.K. to the as food provider technical These
We U.S. rules current our food same distinct it's market, incremental when new market establishes the lines, go consumer the business to the specific its is hemp nutraceutical to direction the believe that. will emerging FDA which from growing
all together operations. it Bringing cash XX, Slide hemp/cannabis on the positive
as our to online First, scale bring operating revenue. resuming execute bulk we on for production enhancement crude additional performance extraction and we gain continue house margin
retail distribution high brands for meet demand consumer new CBD Second, off products consumer our new sites vertical agreements a new to velocity products. products placing expanding at kick top growth channel seeking CBD rapidly
to half not if operating positive it us earlier. with day, opportunities return new get by contract our parameters CDMO+D to XXXX, Just normal growth as cash coupled a stands and organic can first
FDA food another opens We for reliable guidelines the CDMO longer our notable that drug also have term our markets with a capabilities up who in with will of calibrated, solutions. FDA premiums specific of file master customers pricing in to ingredients set opportunities market adjacent with plus sales the nutraceutical large channel demand opens U.S. ingredients precisely new and adjacent repeatable
And finally, on note quick hops.
leveraging in to and with we franchise were unique are engineered accelerate KeyGene of industries. the plant of breeding specific agreement third Our top and new tools identify our genetics. alkaloid nutraceutical early and extensive capabilities, which the expanded new biotechnology beer research hot properly developing to traits XXXX, In benefit traits, techniques consumers we products to our molecular both
I to we past had as the to down what technological progress that's And significant lock as want IP will discuss in turn we filed soon let I Hugh termed the milestone. making detail an financials. is go Hugh? final to give me are work. into clear update to that, this that the on And then be the with over it as able to